
Press Releases
Press Release
NanoString Technologies Releases Operating Results for First Quarter of 2023
– Q1 Revenue of $35.8 Million – – Total Spatial Biology and nCounter Revenue Above Upper End of Q1 Guidance Ranges – – Raising Annual Revenue Guidance to $175-185 Million…
Press Release
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results…
Press Release
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement…
Press Release
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel…
Press Release
NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook
- Generated Record Orders for Over 105 Spatial Biology Instruments, Representing 50% Growth Year-over-Year - - Q4 Revenue Over $34 Million - SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading…
Press Release
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from…
Press Release
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year…
Press Release
NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
Gold Sponsor Workshop Unveils Roadmap to Extend Single Cell Imaging to 6,000-Plex RNA and 120-Plex Protein for the CosMx Spatial Molecular Imager SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a…
Press Release
Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy
First comprehensive spatial atlas of healthy human tissue from multiple organs, including multi-cell and single cell resolution using both GeoMx and CosMx SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a…
Press Release
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
New liver tissue dataset highlights high sensitivity and specificity of CosMx system, and the biological power of spatially analyzing 1000 RNA targets SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a…
Press Release
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
Generated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4 Product and Service Revenue of Over $34 Million, Within Guidance Range of $33 to…
Press Release
National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
Spatial Molecular Imager Locates Rare Senescent Cells in Brain Tissue SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today…